Immunology
News
Consider off-label immunosuppressants for refractory urticaria
News
Annual recurrence rate of anaphylaxis in kids is nearly 30%
Key clinical point: The risk of recurrent anaphylaxis in children who’ve experienced a first episode may be higher than previously recognized....
News
Allergists must standardize penicillin allergy patient testing, advice, and labeling
Key clinical point: There is urgent need to standardize effective testing and reporting methods regarding patients with penicillin allergy. Major...
News
Reslizumab aces pivotal trials in asthma with eosinophilia
Key clinical point: A monoclonal antibody against interleukin-5 significantly reduced the frequency of clinical asthma exacerbations in an...
News
Respiratory harm reversal seen in asthmatic smokers on e-cigarettes
Key clinical point: Asthmatic smokers who adopted physician advice to switch to electronic cigarettes showed significant 1-year improvements in...
News
Early consumption of peanuts can induce tolerance in high-risk children
Key clinical point: Early introduction of peanuts into the diets of children at high risk for peanut allergy can significantly decrease the...
News
Breastfeeding-related changes in gut bacteria protect against childhood allergy
Key clinical point: Breastfeeding helps to alter the gut microbiome of infants, protecting them from pet allergies in childhood.
Conference Coverage
Look for adverse events in patients with chronic urticaria
Key clinical point: The cumulative adverse events of oral corticosteroids may not present to the physician treating the patient for urticaria....
Conference Coverage
Skin patch therapy for peanut allergy wins plaudits
Key clinical point: Epicutaneous immunotherapy in patients with peanut allergy is safe, well-tolerated, and shows dose- and age-dependent efficacy...
Conference Coverage
Get the baby a dog: Infants’ gut biota seen to affect allergy risk
Conference Coverage
EXPECT: Omalizumab pregnancy safety data called ‘reassuring’
Key clinical point: Omalizumab does not appear to increase the risk of birth defects or adverse outcomes in pregnant women and their babies.